In-Vitro Fertilization Market Size to Hit USD 47.70 Billion by 2033

In-Vitro Fertilization Market Size, Share, Growth Trends, Segmental Analysis, By Product (Instruments, Reagents & Media, Disposables & Accessories), By Procedure (Fresh IVF Cycles, Frozen IVF Cycles, Donor Egg IVF Cycles, Embryo Donation), By End User (Fertility Clinics, Hospitals, Clinical Research Institutes, Cryobanks), By Technology (Conventional IVF, ICSI, Preimplantation Genetic Testing, Blastocyst Culture), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), and Market Forecast, 2026 – 2033

  • Published: May, 2026
  • Report ID: 337
  • Pages: 160+
  • Format: PDF / Excel.

This report contains the Latest Market Figures, Statistics, and Data.

Get a Sample
logo

In-Vitro Fertilization Market Size to Hit USD 47.70 Billion by 2033

(An Updated Version is Available)

1. Preface

  • 1.1 Report Description

  • 1.2 Research Scope & Assumptions

  • 1.3 Research Methodology & Data Sources

  • 1.4 List of Abbreviations

2. Executive Summary

  • 2.1 Market Snapshot

  • 2.2 Key Market Highlights

  • 2.3 Analyst Viewpoint & Key Findings

  • 2.4 Strategic Recommendations

3. Market Overview

  • 3.1 Market Definition & Scope

  • 3.2 Value Chain Analysis

  • 3.3 Technology Roadmap & Innovation Pipeline

  • 3.4 Regulatory Landscape & Compliance Framework

    • 3.4.1 U.S. Regulatory Framework (FDA, CDC – Fertility Clinic Success Rate & Certification Act, CLIA '88)

    • 3.4.2 Europe Regulatory Framework (EU Medical Device Regulation, HFEA Guidelines)

    • 3.4.3 Asia Pacific Regulatory Environment (ASPIRE, Country-Level Regulations)

  • 3.5 Pricing Analysis

  • 3.6 Impact of Macroeconomic & Geopolitical Factors

    • 3.6.1 Government Policies & Reimbursement Reforms (U.S. Executive Orders, State Insurance Mandates)

    • 3.6.2 Impact of Declining Birth Rates on IVF Demand

    • 3.6.3 Rising Fertility Tourism & Cross-Border Treatment Trends

    • 3.6.4 Influence of Economic Conditions on IVF Accessibility

  • 3.7 Integration of Artificial Intelligence & Advanced Technologies in IVF

4. Market Dynamics

  • 4.1 Market Drivers

    • 4.1.1 Rising Global Prevalence of Infertility Among Men & Women

    • 4.1.2 Increasing Average Age of Marriage & Delayed Parenthood

    • 4.1.3 Growing Awareness & Acceptance of Assisted Reproductive Technologies (ART)

    • 4.1.4 Government Support & Improving Reimbursement Policies for IVF Treatments

    • 4.1.5 Continuous R&D Investment & Introduction of Advanced IVF Technologies

    • 4.1.6 Rising Adoption of Egg & Sperm Freezing (Vitrification) Procedures

    • 4.1.7 Expansion of Fertility Tourism, Especially in Europe & Asia Pacific

    • 4.1.8 Increasing Demand from Same-Sex Couples & Single Parents

  • 4.2 Market Restraints

    • 4.2.1 High Cost of IVF Treatment & Limited Insurance Coverage

    • 4.2.2 Physical & Psychological Burden Associated with IVF Procedures

    • 4.2.3 Cultural Stigma Around Infertility in Developing Regions

    • 4.2.4 Stringent Regulatory Environment & Compliance Requirements

  • 4.3 Market Opportunities

    • 4.3.1 Integration of AI & Time-Lapse Imaging for Embryo Selection & Viability Prediction

    • 4.3.2 Expansion Through Strategic Acquisitions & Multilocation Clinic Models

    • 4.3.3 Growing Adoption of Preimplantation Genetic Testing (PGT) to Improve Success Rates

    • 4.3.4 Untapped Potential in Emerging Markets (Asia Pacific, Latin America, Middle East & Africa)

    • 4.3.5 Development of Cost-Effective, Automated IVF Laboratory Solutions

  • 4.4 Market Challenges

    • 4.4.1 High Failure Rates in IVF Cycles & Emotional Impact on Patients

    • 4.4.2 Ethical & Legal Concerns Surrounding Donor Gametes & Genetic Screening

  • 4.5 Porter's Five Forces Analysis

  • 4.6 PESTLE Analysis

  • 4.7 Drivers Impact Analysis (% Contribution to CAGR Forecast)

5. In-Vitro Fertilization Market, By Procedure Type

  • 5.1 Overview & Market Share Analysis

  • 5.2 Fresh Nondonor

    • 5.2.1 Market Size & Forecast

    • 5.2.2 Key Trends & Applications

  • 5.3 Frozen Nondonor

    • 5.3.1 Market Size & Forecast

    • 5.3.2 Key Trends & Applications

  • 5.4 Fresh Donor

    • 5.4.1 Market Size & Forecast

    • 5.4.2 Key Trends & Applications

  • 5.5 Frozen Donor

    • 5.5.1 Market Size & Forecast

    • 5.5.2 Key Trends & Applications

6. In-Vitro Fertilization Market, By Instrument

  • 6.1 Overview & Market Share Analysis

  • 6.2 Disposable Devices

    • 6.2.1 Market Size & Forecast

    • 6.2.2 Key Trends & Applications

  • 6.3 Culture Media

    • 6.3.1 Cryopreservation Media

      • Market Size & Forecast

      • Key Trends & Applications

    • 6.3.2 Embryo Culture Media

      • Market Size & Forecast

      • Key Trends & Applications

    • 6.3.3 Ovum Processing Media

      • Market Size & Forecast

      • Key Trends & Applications

    • 6.3.4 Sperm Processing Media

      • Market Size & Forecast

      • Key Trends & Applications

  • 6.4 Equipment

    • 6.4.1 Sperm Analyzer Systems

      • Market Size & Forecast

      • Key Trends & Applications

    • 6.4.2 Imaging Systems (Time-Lapse & AI-Enabled Embryo Monitoring)

      • Market Size & Forecast

      • Key Trends & Applications

    • 6.4.3 Ovum Aspiration Pumps

      • Market Size & Forecast

      • Key Trends & Applications

    • 6.4.4 Micromanipulator Systems

      • Market Size & Forecast

      • Key Trends & Applications

    • 6.4.5 Incubators

      • Market Size & Forecast

      • Key Trends & Applications

    • 6.4.6 Gas Analyzers

      • Market Size & Forecast

      • Key Trends & Applications

    • 6.4.7 Laser Systems

      • Market Size & Forecast

      • Key Trends & Applications

    • 6.4.8 Cryosystems

      • Market Size & Forecast

      • Key Trends & Applications

    • 6.4.9 Sperm Separation Devices

      • Market Size & Forecast

      • Key Trends & Applications

    • 6.4.10 IVF Cabinets

    • 6.4.11 Anti-Vibration Tables

    • 6.4.12 Witness Systems

    • 6.4.13 Others

7. In-Vitro Fertilization Market, By Technology

  • 7.1 Overview & Market Share Analysis

  • 7.2 Intracytoplasmic Sperm Injection (ICSI)

    • 7.2.1 Market Size & Forecast

    • 7.2.2 Key Trends & Applications

  • 7.3 Frozen Embryo Replacement (FER)

    • 7.3.1 Market Size & Forecast

    • 7.3.2 Key Trends & Applications

  • 7.4 Preimplantation Genetic Testing (PGT)

    • 7.4.1 Market Size & Forecast

    • 7.4.2 Key Trends & Applications

  • 7.5 Surrogacy (Donor Egg IVF)

    • 7.5.1 Market Size & Forecast

    • 7.5.2 Key Trends & Applications

  • 7.6 Others (Assisted Hatching, PESA, TESE, Vitrification)

8. In-Vitro Fertilization Market, By End User / Providers

  • 8.1 Overview & Market Share Analysis

  • 8.2 Fertility Clinics

    • 8.2.1 Market Size & Forecast

    • 8.2.2 Key Trends & Demand Drivers

  • 8.3 Hospitals & Other Settings

    • 8.3.1 Market Size & Forecast

    • 8.3.2 Key Trends & Demand Drivers

9. In-Vitro Fertilization Market, By Region

  • 9.1 Overview & Market Share Analysis

  • 9.2 North America

    • 9.2.1 Market Size & Forecast

    • 9.2.2 United States

    • 9.2.3 Canada

  • 9.3 Europe

    • 9.3.1 Market Size & Forecast

    • 9.3.2 France

    • 9.3.3 Germany

    • 9.3.4 Italy

    • 9.3.5 Spain

    • 9.3.6 United Kingdom

    • 9.3.7 Belgium

    • 9.3.8 Netherlands

    • 9.3.9 Switzerland

    • 9.3.10 Norway

    • 9.3.11 Denmark

    • 9.3.12 Sweden

    • 9.3.13 Rest of Europe

  • 9.4 Asia Pacific

    • 9.4.1 Market Size & Forecast

    • 9.4.2 Japan

    • 9.4.3 China

    • 9.4.4 India

    • 9.4.5 Australia

    • 9.4.6 South Korea

    • 9.4.7 Thailand

    • 9.4.8 Singapore

    • 9.4.9 Rest of Asia Pacific

  • 9.5 Latin America

    • 9.5.1 Market Size & Forecast

    • 9.5.2 Brazil

    • 9.5.3 Mexico

    • 9.5.4 Argentina

    • 9.5.5 Rest of Latin America

  • 9.6 Middle East & Africa

    • 9.6.1 Market Size & Forecast

    • 9.6.2 Saudi Arabia

    • 9.6.3 United Arab Emirates

    • 9.6.4 South Africa

    • 9.6.5 Rest of Middle East & Africa

10. Competitive Landscape

  • 10.1 Market Share Analysis of Key Players

  • 10.2 Competitive Benchmarking Matrix

  • 10.3 Market Concentration & Characteristics

  • 10.4 Heat Map Analysis

  • 10.5 Market Positioning of Key Players (2026)

  • 10.6 Strategic Developments & Recent Initiatives

    • 10.6.1 Mergers & Acquisitions

    • 10.6.2 Collaborations, Partnerships & Agreements

    • 10.6.3 Product Launches & Technology Innovation Pipeline

    • 10.6.4 Expansions & Investments

11. Company Profiles (The final report includes a complete list of companies)

  • 11.1 Thermo Fisher Scientific Inc.

    • 11.1.1 Company Overview

    • 11.1.2 Financial Performance

    • 11.1.3 Product Portfolio

    • 11.1.4 Strategic Initiatives

    • 11.1.5 SWOT Analysis

  • 11.2 Vitrolife AB

  • 11.3 CooperSurgical, Inc. (The Cooper Companies, Inc.)

  • 11.4 Cook Medical LLC

  • 11.5 FUJIFILM Irvine Scientific (FUJIFILM Holdings Corporation)

  • 11.6 Genea Biomedx (Genea Pty Limited)

  • 11.7 Merck KGaA (EMD Serono, Inc.)

  • 11.8 Ferring B.V.

  • 11.9 Bayer AG

  • 11.10 Hamilton Thorne Ltd.

  • 11.11 Kitazato Corporation

  • 11.12 Esco Micro Pte. Ltd. (Esco Medical)

  • 11.13 Progyny, Inc.

  • 11.14 IVFtech ApS

  • 11.15 Boston IVF (IVI RMA Global)

12. Investment Analysis

  • 12.1 Investment Landscape Overview

  • 12.2 Mergers & Acquisitions Trend Analysis

  • 12.3 Venture Capital & Private Equity Funding Trends in the IVF Sector

  • 12.4 Key Investment Opportunities by Region & Segment

13. Future Market Outlook & Emerging Trends

  • 13.1 Emerging Technologies Reshaping the IVF Market

    • 13.1.1 AI-Powered Embryo Selection & Viability Prediction Platforms

    • 13.1.2 Robotic & Automated IVF Laboratory Solutions (ICSI Automation)

    • 13.1.3 Expansion of Preimplantation Genetic Testing (PGT) Applications

    • 13.1.4 Next-Generation Vitrification Techniques & Cryopreservation Innovations

    • 13.1.5 Digital & Virtual Fertility Care Platforms

    • 13.1.6 Non-Invasive Embryo Assessment (Metabolomics, Proteomics)

    • 13.1.7 Growth of Fertility Preservation for Oncology Patients

  • 13.2 Future Market Projections (2026–2033)

  • 13.3 Strategic Recommendations for Market Participants

14. Appendix

  • 14.1 Research Methodology

  • 14.2 Data Triangulation & Validation

  • 14.3 List of Tables & Figures

  • 14.4 List of Abbreviations & Acronyms

  • 14.5 About the Publisher

15. Disclaimer

Enhance your decision-making capabilities with a 5 Reports-in-1
Bundle deal for - more than 40% off!

Our professional analysts will provide you with immediate assistance.